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Abstract
Endoscopic submucosal dissection (ESD) was first implemented in early gastric cancer
allowing for en-bloc resection of the lesions. With the experience came the expertise to
introduce ESD for early colon cancer (ECC). ESD demonstrates several advantages in
comparison  with  the  endoscopic  mucosa  resection.  It  allows  accurate  histological
assessment of the depth of invasion, minimizes the risk of local recurrence and helps in
the determination of  additional  therapy.  Indications for ESD are placed only after
adequate endoscopic morphological classification of the lesions excluding higher risk
of nodal metastases.  This chapter provides an overview of the application of ESD
techniques  in  ESD for  ECC and provides  assessment  on  its  technical  aspects  and
complications. In order to decrease the rate of complications a standard protocol for the
ESD should be adopted. The protocol includes recommendations for patient selection,
bowel and patient preparation, appropriate equipment (knives, endoscopes, and power
devices). The chapter will review the current ESD techniques and oncological results.
ESD could have great impact on the treatment of early colon cancer. Its role is already
proven in rectal localizations and despite the challenges it should be adopted for the
colon. Safe strategy for ESD is the cornerstone in decreasing complications,  which
includes suitable resection of specialized ESD devices.
Keywords: Early colon cancer, endoscopic submucosal dissection, minimally invasive
treatment
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1. Introduction
The endoscopic treatment method for gastrointestinal neoplastic lesion has developed in
recent  years.  Another  modality  to  the existing techniques is  the endoscopic  submucosal
dissection which is a novel method which broadens the possibilities for endoscopic treat‐
ment of neoplastic lesion. First introduced in Japan for early gastric cancer, now the method
has advanced and is also applied for early colon cancer. After gaining initial experience the
ESD can be used safely on condition that the indications are strictly followed and the technical
issues and associated complications are recognized. The chapter will review the current ESD
techniques and oncological results. ESD could have great impact on the treatment of early
colon cancer. Its role is already proven in rectal localizations and despite the challenges it
should be adopted for  the colon.  Safe strategy for ESD is  the cornerstone in decreasing
complications, which includes suitable resection of specialized ESD devices.
2. Indications for colonic ESD
The indications for ESD are object of debate. The Colon ESD standardization Implementation
Working Group has proposed a draft of “Criteria of Indications for Colorectal ESD). They
include large-sized (more than 20 mm in diameter) lesion, which are unsuitable for snare
endoscopic mucosal resection, non-granular types of laterally spreading tumours, lesion with
type VI pit pattern, cancer with less than 1000 μm submucosal infiltration, large depressed-
type lesions, large elevated lesion, suspected of cancer [1]. Additional indications for ESD
include sporadic tumours in IBD, local residual carcinoma after endoscopic piecemeal
resection, mucosal lesion with fibrosis, adenoma with non-lifting sign.
The diagnostic process includes chromo-endoscopy, magnified endoscopy, NBI-enhanced
magnified endoscopy or EUS. The histological confirmation of diagnosis is not required
because the adequate chromo-endoscopic evaluation is confirmed to be sufficient. Biopsy is
not always required. The occurring submucosal fibrosis may increases the difficulty of the
procedure and the associated risk [2].
3. Muscle retracting sign
Other useful criteria which may help the selection of patients suitable for ESD is the muscle
retracting (MR) sign. The MR sign is described as retraction of muscularis propria with
submucosal fibrosis. ESD of lesions with positive MR sign is more difficult, which poses as a
threat for a safe procedure [2]. Usually in such cases ESD is aborted. The sign is not universally
exhibited by all larger lesions with protruding areas, despite the morphological similarities.
The conclusion is that MR sign may serve as indication for difficult ESD with risk of resection
failure. Therefore it may indicate patients for surgical resection to avoid adverse events and
complications of the ESD.
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4. CO2 insufflation
The ESD is performed after insufflation of the colon lumen with CO 2, which has been proven
to be effective [3]. It decreases the risk of pneumoperitoneum in cases of perforation and further
complications, related to the ESD.
5. Treatment devices
ESD is technically dependent method and various devices have been introduced. Most of them
have been developed in Japan [1, 4–21] (Figure 1). The devices can be divided in two more
general categories: needle-knife type and grasping type.
Figure 1. Devices used for colonic endoscopic submucosal dssection: A: Flush Knife (Fujifilm Medical, Tokyo, Japan);
B: Flush Knife Ball Tip (Fujifilm Medical, Tokyo, Japan); C: DualKnife (Olympus Medical Systems Co., Tokyo, Japan);
D: B-Knife (Zeon Medical, Tokyo, Japan); E: Splash needle (Pentax Co., Tokyo, Japan); F: Hook Knife (Olympus Medi‐
cal Systems Co., Tokyo, Japan); G: IT Knife 2 (Olympus Medical Systems Co., Tokyo, Japan); H: Clutch Cutter (Fuji‐
film, Tokyo, Japan); I: SB knife Jr (Sumitomo Bakelite); J: Hemostat-Y forceps (PENTAX Medical, Germany).
The needle-type knife device has two modifications – uncovered and covered type. The Flush
Knife (Fujifilm Medical, Tokyo, Japan), the DualKnife (OlympusMedical Systems Co., Tokyo,
Japan), the B-Knife (Zeon Medical, Tokyo, Japan), and the Splash needle (Pentax Co., Tokyo,
Japan) belong to the obtuse, short tipped types [22–24]. As suggested by their name, the Flush
Knife and the Splash needle also have the capability to inject substances in the submucosa.
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This option is very helpful, because it obviates the need to change the injection and the cutting
device during the procedure [23, 25]. Having a ball-disk at the tip, the Dual Knife is able to
hook the submucosa, separate it from the muscularis propria. In contrast to the monopolar
devices, the BKnife is a bipolar knife and therefore it may reduce the risk of complications. The
HookKnife is usually used in cases of poor submucosal elevation [26]. Because of the special
tip, the submucosa can be hooked and separated from muscularis propria and be safely cut
[30]. On the other hand, the DualKnife and the Flush Knife are short tipped and may cause
perforation of the thin wall of the colon in the presence of folds. The Flush Knife has two
modifications – with needle tip and ball tip. Another product of Olympus Medical Systems
Co. is the insulated-tipped knife 2 (IT Knife 2). Its efficacy is reported to be high when used
for gastric lesion [27]. The procedure time is reported to be shortened because of the faster
dissection time due to the longer blade. It also enables coagulation of small vessels. However,
it is difficult to manipulate with this device and the long blade may also cause long perfora‐
tions. A new device was later introduced, called IT knife nano. Its blade is smaller than of the
IT Knife 2 and is targeted for submucosal dissection of the colon.
Author YearCountry Number of cases Main device Generator
Tamegai et al. 2007 Japan 71 Hook Knife
Hurlstone et al. 2007 UK 42 Flex knife, IT knife –
Fujishiro et al. 2007 Japan 200 Flex knife, Hook Knife, electrosurgical knife ICC-2(X) or VI0300D
Zhou et al. 2009 China 74 Needle-knife, IT knife, Hook Knife ICC-200
Isomoto et al. 2009 Japan 292 Flex knife, Hash knife, Hook Knife ICC-200 or VI0300D
Saito et al. 2009 Japan 405 Bipolar needle knife (B-knife), IT knife –
Iizuka et al. 2009 Japan 38 Flex knife ICC-200 or VI0300D
Hotta et al. 2010 Japan 120 Flex knife, Flush Knife, Hook Knife ICC-200 or VI0300D
Niimi et al. 2010 Japan 310 Flex knife, Hook Knife, electrosurgical knife ICC-200 or VI0300D
Yoshida et al. 2010 Japan 250 Flush Knife VI0300D
Toyonaga et al. 2010 Japan 512 Flex knife, Flush Knife –
Matsumoto et al. 2010 Japan 203 Flex knife, Hook Knife, Dual Knife –
Uraoka et al. 2011 Japan 202 B-Knife, Dual Knife, IT knife, mucoscctome –
Shono et al. 2011 Japan 137 Flush Knife, Hook Knife, precutting knife –
Kim et al. 2011 Korea 108 Flex knife, Hook Knife VI0300D
Lee et al. 2011 Korea 499 Flex knife, Hook Knife VI0300D
Probst et al. 2012 Germany 76 Hook Knife, IT knife, triangle knife VI0300D
Okamoto et al. 2013 Japan 30 Dual Knife, mucosectome-2 VI0300D
Nawata et al. 2014 Japan 150 SB knife Jr, IT knife nano –
Table 1. List of most commonly used devices and generators.
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The grasping type devices have two major representatives – Clutch Cutter device (Fujifilm,
Tokyo, Japan) and SB knife Jr (Sumitomo Bakelite) [21, 28]. The cutting method involves use
of grasping type scissor forceps. It avoids fixing the knife to the target, although their use is
associated with higher risk of perforation and bleeding after unexpected bowel movement [28].
Another useful device is the Hemostat-Y forceps (H-S2518; Pentax Co., Tokyo, Japan), which
is used in bipolar mode to control visible bleeding and minimize the risk of any burning effect
on the muscle layer. Some authors describe the use of double-balloon colonoscope in cases of
difficult lesion location or to avoid paradoxical movement [29]. The procedure requires
electrosurgical device. On Table 1 are presented the most commonly used generators.
6. Practical aspects of the ESD
The bowel preparation is essential for a successful ESD. Any feces and liquid should be cleared
from the colon. If any still remains in the lumen, ESD should not be initiated. The feces do not
only prevent adequate dissection, but also pose as a serious treat in case of perforation.
A single channel general lower gastrointestinal endoscope is used for the procedure. Some
centres have adopted the use of upper gastrointestinal endoscope. It is slimmer and can be
used in retroflexed position [4]. The tip of the endoscope can be fitted with a transparent cap
(Olympus Medical Systems Co., Tokyo, Japan).
ESD starts with submucosal injection. It is crucial to maintain adequate elevation during the
procedure. Different solutions have been used. Some centres use in their practice two solutions:
Glyceol (10% glycerin and 5% fructose; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan) mixed
with a small amount of Indigo Carmine and epinephrine, and 0.4% sodium hyaluronate
solution (MucoUp; Seikagaku Corp, Tokyo, Japan) [30]. First, small amount of Glyceol is
injected in the submucosal layer to confirm the appropriate localization and then MucoUp is
injected until proper elevation is achieved. The final step is to inject small amout of Glyceol to
flush the residual MucoUp [31]. Repeated submucosal injections are required during the
procedure to maintain adequate submucosal elevation [29].
7. Sedation
ESD is usually a long procedure and can continue for more than 2.5 hours. Additionally, the
abdominal discomfort caused by gas insufflation causes restlessness. Restlessness due to
abdominal fullness and pain occurs frequently in cases with an operation time exceeding 2.5
h. Several medicaments are used for sedation. Some authors report use of midazolam and
pentazocine with monitoring by automatic blood pressure monitor. They observed restless‐
ness in 15 out of these 22 cases (68.1%) despite conscious sedation when the procedure lasted
more than 2.5 hours. When the procedure lasted less than 2.5 h, restlessness was observed in
only 10 out of 83 cases (12.0%) [32]. Carbon dioxide insufflations have also been reported to
be effective for the prevention of abdominal fullness [33]. Another option is the use of propofol
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for conscious sedation which could be used for longer procedure without restlessness and
discomfort [10].
8. Technique of ESD
The process of ESD is divided in several consecutive steps which are presented on Figure 2.
After adequate elevation of the mucosa has been achieved, the process is initiated. The first
step is mucosal incision and simultaneous incision to the deep submucosa layer. The lifting
solution is injected at the proximal end of the lesion and mucosal incision is made. Sometimes
the insertion of the endoscopic tip into the submucosal layer may become difficult and in these
cases trimming of the mucosa is performed. To clear space for dissection after the trimming
the submucosal layer near the mucosa is precisely cut. One of the practices for the mucosal
incision is to circumvent the tumour. In cases where partial circumferential incision is
performed the proximal side of the lesion is incised after the submucosal injection. Various
endocut modes are recommended for the incision, which depend on the generator used. The
described techniques for incision have their advantages and disadvantages. The circumferen‐
tial incision may lead to undesired leakage of lifting liquid and loss of submucosal elevation.
When injected at the distal side the tumour takes perpendicular to the endoscope position,
which may hamper the dissection. The remaining uncut mucosa at the distal side pulls the
tumour upward and also changes the position of the tumour. These situations are observed
for tumours larger than 50 mm. When the incision is partially circumferential the elevation of
the mucosa is easily maintained, because the uncut residual mucosa prevents liquid leakage.
On the other hand after the partial resection of the tumour, the residual mucosa may become
difficult for resection. Therefore each approach has its advantages and disadvantages. The
specific type of incision should be chosen according to the tumour characteristics such as size,
Figure 2. Steps of endoscopic submucosal dissection for early stage colon cancer: A: electrocautery marking around the
lesion; B: injection of solution underneath the lesion; C: incision around the lesion; D: lifting and removal of the lesion;
E: extraction of the tumor; F: meticulous hemostasis.
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location, types of knives. During the submucosal dissection, the endoscopist can easily
recognize the advantages of ESD. Structures such as vessels, fibrosis, etc. are clearly visible.
Hemorrhage is controlled by precoagulation of the blood vessels. The thinner vessels are
coagulated by cutting devices. The thicker ones can be dealt with forceps. Unlike for adenom‐
atous lesion, in cases of early colon cancer the cutting line should be near the mucosal layer in
order to achieve R0 resection. This step should be carried out with precision due to the higher
perforation risk. The ESD is only finalized after careful inspection for any bleeding vessels. If
any are found these are coagulated.
9. Complications
ESD in the colon is technically challenging procedure due to the anatomical characteristic of
the colon. The latter is a long luminal organ with many folds, which impede the manipula‐
tion of the endoscope. The thin walls are easier to penetrate in comparison to the gastric wall.
The insuflated gas during longer procedures may cause paradoxical movement of the
endoscope. This situation occurs specifically in tumour, located above the sigmoid colon. It
is difficult to find specific studies only on colon ESD. Therefore the presented data will cover
also outcomes of colorectal ESD, bearing in mind that the rectal manipulations are easier due
to the length of this segment. The rate of perforation of ESD is dramatically high when
compared with that observed for endoscopic mucosal resection (EMR) [34–36] and has been
reported to be 1.4–10.4%. According to several clinical studies the predicting factors for
perforation are large lesions (>30 mm), fibrosis, colonic location and less experience with ESD
[12, 22, 37, 38]. (Table 2).
The use of knife coagulation is considered the most common cause of perforation [39]. As
described in the previous section, the obtuse knives such as DualKnife and the Flush Knife can
easily cause perforation. In contrast the Hook Knife is able to hook up the mucosa, separate it
from the submucosal layer and cut it safely. Other reasons for perforation include snare
resection, coagulation by special haemostatic forceps with soft coagulation, endoscopic
clipping onto coagulated submucosa [39]. The complications following ESD for colon tumour
can be severe and even fatal in case of peritonitis. Alarming symptoms for perforation are
abdominal tympanism, emphysema, and abdominal pain and muscle resistance. Most of the
perforation cases are treated conservatively without emergency surgery. Although the closure
of the mucus defect is practiced in several centres in Japan, this practice is currently considered
impractical and technically challenging with the available devices, e.g. hemo-clips. Endoscopic
clipping is possible for small perforation [40, 41]. The abdominal distention can be treated by
decompression of the peritoneum via 20 Fr needle [10]. A new closure device which consists
of clip with a loop may come in handy [42]. In some cases the perforation is not detected during
endoscopy and only later on computed tomography. The possible explanation is that micro‐
perforations occur during ESD on deep injection by the needle. Those cases are not clinically
significant and can be safely treated by conservative measures, such as stopping of oral intake.
Another specific case of perforation is the delayed perforation. It accounts to 0.3% to 0.7% of
the perforations [4, 5, 43] and is considered to be related to excessive coagulation in the
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muscularis propria. Usually delayed perforations are large in size and therefore require
emergency surgery [4, 5, 43]. Bleeding after ESD is another common complication. The usual
practice is to cut any vessel below 2 mm in diameter with a knife in coagulation mode. For
vessels larger than 2 mm in diameter, a special haemostatic forceps should be used in soft
coagulation mode. These forceps have the ability to gently catch the vessel and lift it upwards
from muscularis propria. The surrounding mucosa around the vessel is also resected with the
forceps. Removal of the coagulated vessel and the surrounding submucosa ensures safer and
easier submucosal dissection. In cases when bleeding cannot be stopped by the knife the
haemostatic forceps can be used as well with SOFT coagulation mode. The rate of postoperative
haemorrhage in ESD is reported to be 0–12.0% (Table 1) [4, 5, 8–10, 22, 23, 25, 26, 44]. Most
cases of postoperative haemorrhage are treated only by endoscopic clipping and withholding
oral intake without emergency surgery or blood transfusion.
Author Year Country Number of cases Post-ESD perforation rate Bleeding rate
Tamegai et al. 2007 Japan 71 – 1.4%
Hurlstone et al. 2007 UK 42 2.4% 9.5%
Fujishiro et al. 2007 Japan 200 6.0% 0.5%
Zhou et al. 2009 China 74 8.1% 1.4%
Isomoto et al. 2009 Japan 292 7.9% 0.7%
Saito et al. 2009 Japan 405 3.5% 1.0%
Iizuka et al. 2009 Japan 38 7.9% –
Hotta et al. 2010 Japan 120 7.5% –
Niimi et al. 2010 Japan 310 4.8% 1.6%
Yoshida et al. 2010 Japan 250 6.0% 2.4%
Toyonaga et al. 2010 Japan 512 1.8% 1.6%
Matsumoto et al. 2010 Japan 203 6.9% –
Uraoka et al. 2011 Japan 202 2.5% 0.5%
Shono et al. 2011 Japan 137 3.6% 3.6%
Kim et al. 2011 Korea 108 20.4% –
Lee et al. 2011 Korea 499 7.4% –
Probst et al. 2012 Germany 76 1.3% 7.9%
Okamoto et al. 2013 Japan 30 0.0% 0.0%
Nawata et al. 2014 Japan 150 0.0% 0.0%
Table 2. Rate of complications after colorectal ESD from single center studies.
Another common effect after ESD is local inflammation to a certain degree. C-reactive protein
level may rise to 5,82 ± 12.10 mg/L 2 days after the procedure in cases with perforation and
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1.27 ± 2.00 mg/L in cases without perforation [45]. Fever and abdominal pain were also reported
without perforation. A rare complication was acute colon obstruction after ESD of a colonic
tumour located at the cecal base [46].
10. Clinical Studies on Colorectal ESD
Several large series on colorectal ESD have been published from Asian centres. However, most
of the data are retrospective, and direct prospective comparative data on ESD versus EMR or
surgery are not available. The Japan Society for Cancer of the Colon and Rectum conducted a
multi-centre, observational study for all patients treated by conventional endoscopic resection
and ESD for colorectal neoplasms exceeding 20 mm in size from October 2007 to December
2010 [9]. A total of 816 lesions were treated by ESD and the short-term outcomes were as
follows. The mean lesion size was about 40 mm in diameter. En bloc resection was achieved in
more than 90% of the cases, regardless of lesion size, with a perforation rate of 2.0% and delayed
bleeding rate of 2.2%. None of the perforation cases needed emergency surgery as most
Author Year Country Number of cases En bloc resection rate Complete en bloc resection rate
Tamegai et al. 2007 Japan 71 98.6% 95.8%
Hurlstone et al. 2007 UK 42 78.6% 73.8%
Fujishiro et al. 2007 Japan 200 91.5% 70.5%
Zhou et al. 2009 China 74 93.2% 89.2%
Isomoto et al. 2009 Japan 292 90.1% 79.8%
Saito et al. 2009 Japan 405 86.9% –
Iizuka et al. 2009 Japan 38 60.5% 57.9%
Hotta et al. 2010 Japan 120 93.3% 51.0%
Niimi et al. 2010 Japan 310 90.3% 74.5%
Yoshida et al. 2010 Japan 250 86.8% 81.2%
Toyonaga et al. 2010 Japan 512 98.2%
Matsumoto et al. 2010 Japan 203 – 85.7%
Uraoka et al. 2011 Japan 202 90.6% –
Shono et al. 2011 Japan 137 89.1% 85.4%
Kim et al. 2011 Korea 108 – 78.7%
Lee et al. 2011 Korea 499 95.0% –
Probst et al. 2012 Germany 76 81.6% 69.7%
Okamoto et al. 2013 Japan 30 100.0% –
Nawata et al. 2014 Japan 150 98.7% 97.3%
Table 3. Rate of en-bloc resections and complete en-bloc resections after colorectal ESD from single center studies.
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iatrogenic perforations is very small, and can be successfully closed with endoscopic clip
placement alone followed by intravenous antibacterial therapy (nothing per os).
A recent systematic review reported resection rates of 90.5% (61–98.2%) for endoscopic en bloc
resection and of 76.9% (58–95.6%) for histologically confirmed complete resection, with
associated local recurrence rates of 1.9% (0–11%) (Table 3) [30]. In addition, there are several
studies with >500 ESD procedures, including large single centre series [47, 48], multi-centre
surveys [49, 50], and a prospective multi-centre study [51]. These series confirm the high “en
bloc” resection rates (up to 88.8% histologically confirmed complete resections) and the
reported complication rates (perforation 4.8–5.4%, delayed perforation 0.4–0.7%, bleeding 1.5–
1.7%). It was also demonstrated that ESD is feasible not only for the resection of adenoma or
superficial cancers, but is also curative for submucosal invasive cancer. Thus, submucosal
invasion limited to the upper 1,000 inlinegraphic m of the submucosal layer (sm1) is sufficiently
treated with local resection if the tumour has a G1/G2 differentiation and no lymphatic or
vascular invasion (L0, V0) [52–55]. When compared to EMR, data on ESD consistently show a
higher en bloc resection rate/lower recurrence rate. Thus, in an analysis of 26 studies on EMR,
en bloc resection for relatively smaller target lesions was possible in only 42.6% (19.2–91.8%)
and recurrence rates were 17% (4.8–31.4%) for lesions resected in a piecemeal fashion [9]. In
addition, several retrospective case series [35, 56–58], a matched case control analysis [59], and
a meta-analysis [60] were published on the comparative analysis of EMR versus ESD. All these
reports show a higher efficacy of ESD for the resection of larger sessile or flat lesions, resulting
in a lower recurrence rate. When analysing risk factors for adenoma recurrence after EMR,
associations were reported with size and morphology of the lesions (higher risk of incomplete
resection for serrated adenoma/flat adenoma), piecemeal resection, and number of fragments
[61–65]. Data on complications after EMR/ESD show similar bleeding rates (EMR 0–11.1%;
ESD 0.5–9.5%), but the perforation rate is higher for ESD (1.3–20%) than for EMR (0–5.8%).
However, the vast majority of perforations occurring during ESD are small and easily treated
during the procedure, and thus the actual need for emergency surgery does not differ for EMR
versus ESD [14, 18, 49, 66–68]. ESD is technically demanding and does require long procedure
times. Thus, a recent study comparing 1,029 cases of conventional EMR with 816 ESD proce‐
dures showed a significantly higher procedure time for ESD (96 min) than for EMR (18 min).
Procedure times increased with the size of the lesion, although for very large lesions a
comparison to laparoscopic surgery would be more appropriate [66, 67]. Comparative data
are available for ESD versus surgery, but again without a formal head-to-head study. Two
smaller retrospective studies found no significant difference for efficacy (including procedure
time) and safety between ESD versus transanal endoscopic microsurgery (TEM) for the
treatment of early rectal cancer [69, 70]. A recently published systematic review and meta-
analysis of 11 ESD and 10 TEM studies showed higher en bloc resection rates and a reduced
need for additional surgery for TEM, while recurrence rates were significantly lower after ESD
and no difference in the overall complication rate was observed [71]. Finally, a comparative
retrospective study from the National Cancer Centre Tokyo found that ESD is equally effective
as laparoscopic surgery for the treatment of early colorectal cancer, with significantly lower
complication rates and shorter procedure times [72]. Indeed, the accompanying editorial called
for an initiative to disseminate ESD for optimal treatment of early colorectal cancer [73]. While
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larger studies on colorectal ESD are almost exclusively from Asia, data on colorectal ESD from
Western countries is mostly limited to the distal colon [9, 19, 74–77](Table 1). Taken together,
there are considerable advantages of ESD over EMR for the resection of larger sessile or flat
lesions, in particular high enbloc resection rates and low recurrence rates. The major problem
of ESD is the technical challenge and the relatively long procedure time. Compared with
surgery, ESD shows similar performance as TEM for rectal lesions, while a clear advantage –
both for clinical outcome and procedure time – was observed in a single comparative study
for ESD versus laparoscopic surgery for the treatment of T1 colorectal carcinoma. Nevertheless,
there still is a need for prospective comparative trials to better define the role of ESD in
comparison to EMR or surgery.
11. Conclusion
ESD is an attractive endoscopic treatment modality for larger sessile or flat adenomas/
superficial or slightly submucosal invasive colorectal cancers. ESD is a reliable method for
achieving en bloc resection of relatively large colorectal superficial neoplasms, with superior
curability. Still, ESD is associated with technical difficulties and complications, including
perforation. Therefore patients should be selected for ESD only according to strict criteria,
including tumour characteristics. The prerequisite for ESD is proper diagnosis, established by
magnifying endoscopy, endoscopic ultrasound, etc. While colorectal ESD has recently become
a standard procedure in major Asian endoscopy centres, propagation of ESD in Western
countries will critically depend on opportunities for specialized training and probably also on
technical developments to facilitate ESD and reduce procedure times.
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